A sick dog, desperate owner, and a bunch of chatbots made for a great story. The actual science was much messier.

Researchers are redesigning lipid nanoparticles to do more than shuttle mRNA into cells, with preclinical studies suggesting ...

Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential ...

Vaccine programs are being challenged by rising misinformation and an uncertain pipeline for research funding, the World ...

Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than treatments, now in clinical ...

Penn Engineers have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal immunotherapy ...

"Falling vaccination rates, inadequate health policy, and a lack of preparedness can trigger a crisis that brings an entire ...

The updated 2024-2025 mRNA COVID-19 vaccine was linked to moderate protection against severe COVID-19 outcomes, including hospitalizations.

Scientists have shown that a single injection of self-amplifying RNA, delivered into skeletal muscle rather than the heart ...

When his beloved dog was given months to live, an Australian man harnessed the power of machine learning and mRNA technology ...

Aro Biotherapeutics, a clinical-stage biotechnology company developing potent and tissue-targeted short-interfering RNA (siRNA) medicines in areas of high unmet need in rare muscle diseases, ...

Penn Engineers have redesigned the lipid nanoparticles (LNPs) used to deliver mRNA vaccines, showing that subtle changes in lipid chemistry can influence immune cell metabolism and reduce inflammation ...